Giusti, Massimo <br/><br/>
Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.  [electronic resource] 

 -  Metabolism: clinical and experimental  May 2007 
 - 699-707 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1016/j.metabol.2007.01.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Alkaline Phosphatase--blood<br/>Bone and Bones--drug effects<br/>Calcium--blood<br/>Case-Control Studies<br/>Cohort Studies<br/>Creatinine--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoprotegerin--blood<br/>Parathyroid Hormone--blood<br/>Phosphorus--blood<br/>RANK Ligand--blood<br/>Thyroid Hormones--blood<br/>Thyroid Neoplasms--blood<br/>Thyrotropin--antagonists & inhibitors<br/>Thyroxine--administration & dosage